Oseaspre Consultants Schedules Board Meeting on May 15, 2026 to Consider Q4FY26 Audited Results and Dividend

Oseaspre Consultants has notified BSE Limited of an upcoming Board of Directors meeting, scheduled for Friday, May 15, 2026, in compliance with Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The intimation was submitted on May 11, 2026, and signed by Ganesh S. Pardeshi, Company Secretary (Membership No.: A29080).

Board Meeting Details

The following key agenda items have been disclosed for the upcoming board meeting:

Parameter:	Details
Meeting Date:	Friday, May 15, 2026
Regulatory Provision:	Regulation 29, SEBI (LODR) Regulations, 2015
Agenda Item 1:	Consideration and approval of Audited Financial Results for Q4 and FY ended March 31, 2026
Agenda Item 2:	Recommendation of dividend, if any, for the financial year ended March 31, 2026
Intimation Date:	May 11, 2026

Key Agenda Items

The board is set to deliberate on the following during the meeting:

Audited Financial Results: Consideration and approval of the audited financial results for the quarter and financial year ended March 31, 2026
Dividend Recommendation: Deliberation on the recommendation of dividend, if any, for the financial year ended March 31, 2026

Regulatory Compliance

The intimation has been filed in accordance with the provisions of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which mandates listed companies to notify stock exchanges in advance of board meetings where financial results or dividend recommendations are to be considered. The company has requested BSE Limited to take the aforesaid information on record.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

Technojet Consultants Limited has announced the divestment of its equity stake in INOR Medical Products Limited through a regulatory filing dated 25th February, 2026. The transaction represents a strategic portfolio adjustment by the company as it exits its investment in the unlisted medical products manufacturer.

Transaction Details

The divestment involves the complete sale of Technojet Consultants Limited's holding in INOR Medical Products Limited. The company has disclosed the transaction details in compliance with regulatory requirements.

Parameter:	Details
Shares Sold:	48,000 Equity Shares
Target Company:	INOR Medical Products Limited (Unlisted)
Buyer:	Nowrosjee Wadia and Sons Limited
Disclosure Date:	25th February, 2026
Filing Time:	16:41:04 +05'30'

Regulatory Compliance

The announcement was made pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. This regulation mandates listed companies to disclose material events and information that could impact investor decisions.

The disclosure was signed by Bhumika Ojha, Company Secretary (Membership No.: A79488), ensuring proper corporate governance protocols were followed. The digital signature was applied on 25th February, 2026, at 16:41:04 +05'30', confirming the authenticity of the regulatory filing.

Corporate Background

Technojet Consultants Limited operates under CIN L74210MH1982PLC027651 and maintains its listing on BSE Limited with scrip code 509917. The company's decision to divest from INOR Medical Products Limited reflects its ongoing portfolio management strategy, though specific financial details of the transaction were not disclosed in the regulatory filing.